Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Stage

Merger | Merged

Total Raised

$2.6M

About PROXY Laboratories

PROXY Laboratories BV ('PROXY') is a contract laboratory, with a focus on quality control of (bio) pharmaceutical raw materials and medicines, stability studies and validation of analytical methods for the (bio) pharmaceutical industry.

PROXY Laboratories Headquarter Location

Netherlands

Latest PROXY Laboratories News

PROXY Laboratories - Part of Sinensis Life Sciences

Jul 2, 2013

Bactimm-Farma Holding and PROXY Labs Holding Merge to Form Sinensis  Life Sciences   January 31, 2013, Leiden, the Netherlands   The two leading independent contract laboratory service providers for the (bio)pharmaceutical industry Bactimm-Farma Holding and PROXY Labs Holding, today announce the merger of their business operations. The new company will be named Sinensis Life Sciences and will have its corporate headquarters in the BioScience Park Leiden, the Netherlands. Since early 2012, the management buy-out of PROXY Laboratories which was soon followed by the acquisition of MicroSafe Laboratories, has led to Jonghoud being the major investor in both groups of laboratories. The merger of these groups is a logical step as it brings together the two biggest Dutch independent contract laboratory service providers in the life sciences. Sinensis Life Sciences comprises more than 130 employees and includes five sites from which over 400 sponsors from all over the world are supported and offers a broad services portfolio to the outsourcing market through a complementary business model. It is active in Pharmaceutical Chemistry, Pharmaceutical Microbiology, BioSafety Testing, Analytical R&D and Contract Manufacturing. Commenting on the merger, Dr. Ruud Santing, Chief Executive Officer of Sinensis Life Sciences, said: “This merger provides a strong foundation for growth in the business, as we build and expand Sinensis Life Sciences into different areas of the life sciences market. I am confident that the quality, organisational strength and financial scale will provide our clients with the comfort feeling in terms of quality and efficiency that they are already familiar with.”   Bactimm-Farma Holding consists of Bactimm in Nijmegen, Farmalyse in Zaandam and Prolepha Labs in Etten-Leur, while PROXY Labs Holding consists of PROXY Laboratories and MicroSafe Laboratories, both in Leiden. More information can be found on the new corporate website www.sinensislifesciences.com . For further information, please contact: Jan de Vries, Director Marketing & Sales, via telephone number +31-(0)71-5244080 or via e-mail j.devries@sinensislifesciences.com  

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.